Sign In
Buy PFE
$25.69
+0.335 (+1.32%)
At Close: Jun 04, 2026
BMO Capital Markets' Evan Seigerman: I'm encouraged by Pfizer raising 2025 profit outlook
02:40pm, Tuesday, 05'th Aug 2025
Evan David Seigerman, BMO Capital Markets managing director & healthcare head, joins CNBC's 'Squawk on the Street' to discuss outlooks on Pfizer.
Pfizer Q2 Earnings Beat Estimates, Oncology Drives Top-Line Growth
12:50pm, Tuesday, 05'th Aug 2025
PFE posts strong Q2 results with earnings up 30% and revenues up 10% year over year, fueled by rising oncology sales and cost cuts.
Trade Deficit Narrowed More Than Expected
12:05pm, Tuesday, 05'th Aug 2025
Pre-market futures are in the green across major indexes this morning, but experiencing a bit of choppiness. The Dow and S&P 500 are both up mere single-digits at this hour, off the early-morning high
Pfizer Stock Pops on Q2 Beat-and-Raise
11:01am, Tuesday, 05'th Aug 2025
The shares of Pfizer Inc (NYSE:PFE) were last seen up 4.9% to trade at $24.4, after the pharmaceutical giant's second-quarter results beat expectations.
Here's What Key Metrics Tell Us About Pfizer (PFE) Q2 Earnings
10:32am, Tuesday, 05'th Aug 2025
While the top- and bottom-line numbers for Pfizer (PFE) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to W
Buy Pfizer Stock At $24?
09:55am, Tuesday, 05'th Aug 2025
Pfizer (NYSE: PFE) has recently reported impressive second-quarter results, with both revenue and earnings exceeding analyst expectations. The company disclosed adjusted earnings of $0.78 per share on
Pfizer raises profit forecast after Q2 earnings beat estimates
09:35am, Tuesday, 05'th Aug 2025
Pfizer Inc (NYSE:PFE, ETR:PFE) raised its full-year profit outlook on Tuesday after posting better-than-expected second-quarter earnings, driven by strong sales of key drugs including Comirnaty and Pa
Pfizer stock pops as big pharma giant delivers post-COVID comeback
09:03am, Tuesday, 05'th Aug 2025
Pfizer stock (PFE: NYSE) surged on Tuesday after the company delivered stronger-than-expected second-quarter results and lifted its profit outlook for the year. Revenue climbed 10% to $14.7 billion, t
Pfizer (PFE) Surpasses Q2 Earnings and Revenue Estimates
08:56am, Tuesday, 05'th Aug 2025
Pfizer (PFE) came out with quarterly earnings of $0.78 per share, beating the Zacks Consensus Estimate of $0.58 per share. This compares to earnings of $0.6 per share a year ago.
S&P 500 Pre-Market: Pfizer Jumps on Profit Hike While Yum Brands Struggles With US Sales
07:32am, Tuesday, 05'th Aug 2025
Pfizer raises 2025 profit forecast after strong Q2 results, while Yum Brands struggles with weak US sales at KFC and Pizza Hut. Full earnings breakdown inside.
Pfizer raises annual profit forecast
06:53am, Tuesday, 05'th Aug 2025
U.S. drugmaker Pfizer raised its full-year profit forecast on Tuesday after reporting better-than-expected results for the second quarter, boosted by strong demand for its heart disease drug, Vyndaqel
Pfizer hikes 2025 profit outlook on cost cuts, strong quarterly results
06:52am, Tuesday, 05'th Aug 2025
Pfizer hiked its full-year adjusted profit guidance on its cost cuts and strong business performance this year. The company also reported second-quarter results that topped Wall Street's estimates for
Pfizer Reports Strong Second-Quarter 2025 Results And Raises 2025 EPS Guidance
06:45am, Tuesday, 05'th Aug 2025
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) reported financial results for the second quarter of 2025 and reaffirmed its 2025 Revenue guidance while raising guidance(1) for Adjusted(2) diluted
3 Healthcare Stocks Paying the Highest Dividends of 2025
05:50am, Tuesday, 05'th Aug 2025
The healthcare sector has long been a favorite for income investors -- and for good reason. Many healthcare stocks offer attractive dividend yields.
3 Ultra-High-Yield Dividend Stocks -- Sporting an Average Yield of 6.72% -- That Make for No-Brainer Buys in August
03:51am, Tuesday, 05'th Aug 2025
Over the last century, no asset class has generated a higher average annualized return for investors than stocks. Though there are countless way for investors to put their money to work on Wall Street
